tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Similar Stocks

Compare
168 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
NewAmsterdam Pharma Company
$21.76
$2.39B
-7.99%
9 Buy
0 Hold
0 Sell
Strong Buy
Amarin
$0.44
$181.18M
-49.43%
0 Buy
1 Hold
0 Sell
Hold
Madrigal Pharmaceuticals
$327.87
$7.24B
32.41%
14 Buy
0 Hold
1 Sell
Strong Buy
Esperion
$1.50
$296.77M
-44.44%
4 Buy
0 Hold
1 Sell
Moderate Buy
Viking Therapeutics
$25.65
$2.88B
-68.72%
15 Buy
1 Hold
0 Sell
Strong Buy
Akero Therapeutics
$42.72
$3.40B
75.15%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NAMS
NewAmsterdam Pharma Company
21.76
0.39
1.82%
AMRN
Amarin
0.44
-0.44
-50.00%
MDGL
Madrigal Pharmaceuticals
327.87
72.13
28.20%
ESPR
Esperion
1.50
-1.29
-46.24%
VKTX
Viking Therapeutics
25.65
-53.85
-67.74%
AKRO
Akero Therapeutics
42.72
18.65
77.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis